Skip to Content
Donate

Leadership Team

Dr. Jan Hux

Dr. Jan Hux

President and CEO

Dr. Jan Hux is the President and CEO of Diabetes Canada. She is an accomplished strategic leader who brings exceptional insight into the Canadian diabetes epidemic and is guiding the organization as it executes a renewed strategy of delivering a greater impact to those affected by or at risk of diabetes at a broader population level rather than only reaching individuals locally or at a community base. Jan brings years of experience as a clinician-scientist, trained as a general internist and health services researcher. She holds an MD from the University of Toronto and a Masters in Epidemiology from Harvard. She has held a variety of research and executive roles at the Institute for Clinical Evaluative Sciences (ICES) in Ontario, where she was responsible for developing and leading the diabetes health services research portfolio. She has over 100 peer-reviewed publications.

In her role at Diabetes Canada, she provides strong executive leadership as the organization sharpens its focus on delivering population impact through investments in prevention, diabetes management and research.

John Reidy

John Reidy

Chief Operating Officer

Mary Ann Azzarello

Mary Ann Azzarello

Vice President, Fund Development

Halinka Dybka

Halinka Dybka

Vice President, Marketing & Knowledge Innovation

Seema Nagpal

Dr. Seema Nagpal

Vice President,  Science & Policy

Seema Nagpal is an epidemiologist with broad experience in research and policy. She has expertise in population health, epidemiology, and pharmaceutical sciences with an emphasis on interpretation of science into policy and practice. As the Epidemiologist and Senior Leader, Public Policy at Diabetes Canada, she is responsible for directing public policy interests and activities at both the federal and provincial levels, as well as providing public health and epidemiological input to program and policy development for Diabetes Canada. She is also responsible for analyzing the impact of public policy and regulations flowing from government, health stakeholders, academia and overseeing the developing policy options and positions to influence health and diabetes-related public policy.

Sean Shannon

Sean Shannon

President and CEO
National Diabetes Trust

Sean Shannon is the President and CEO of National Diabetes Trust (NDT), the social enterprise that operates the collection of household textiles and small items.  One hundred percent of net proceeds raised by NDT directly supports the work of Diabetes Canada.  NDT also diverts 100 million pounds of textiles a year through the collection and sale of these items.  He joined NDT in February 2019 and brings 35 years of cross-functional business experience across numerous consumer-facing well known brands.  Prior to joining NDT, he was Chief Operating Officer of Busbud, Inc., a global online consumer marketplace for purchasing city to city bus tickets.  Previous, he was Managing Director of Expedia Canada and Latin America over a 14 year span, and one of 4 founding employees for this business unit.  He began his career in marketing at Procter & Gamble, and also was a Vice President at Molson Breweries for 10 years.  Sean holds an Honours degree (HBA) from Ivey School of Business, Western University.. 

Russell Williams

Russell Williams

Senior Vice President, Mission

Russell is the senior vice-president, mission at Diabetes Canada. He leads his team and dedicated volunteers in the organization’s advocacy efforts at all levels of government for public policy change that will better support people with diabetes and their families, from improved access to medications and devices to strategies to improve the health of all Canadians and support type 2 diabetes prevention.

He is the former president of Innovative Medicines Canada (formerly Rx&D), an influential association of over 50 pharmaceutical companies, a leading voice of the innovative life science sector in Canada. His leadership included working with all governments at the Federal and Provincial levels, both at political and administrative levels, and he was involved in numerous task forces on pharmaceutical policy, and also participated in a number of key international coalitions focused on improving research, health care and ethics networks. Russell chaired the Code Compliance Network for the IFPMA, and since 2011, served as the primary private sector lead for the APEC biopharmaceutical ethics initiative, a group of 21 countries that developed international principles for business ethics. In 2015, he was named Industry Co-Chair of the APEC Biopharmaceutical Working Group on Ethics set up by the U.S. Department of Commerce to support the initiative. Prior to his appointment as President of Innovative Medicines Canada, Russell served as the Member of the Quebec National Assembly for the riding of Nelligan. Ethics and integrity in the pharmaceutical and medical fields have always been a passion of Russell's, and in November of 2016, Innovative Medicines Canada and Queen’s University announced the creation of the Russell Williams Studentship in Medical Ethics in his honour.